ACTINIUM PHARMACEUTICALS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Deferred Tax Assets, Goodwill and Intangible Assets of $18.68 million as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2024-03-29
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $18.68M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $13.21M.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $10.43M.
- 2020-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $7.87M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets | Deferred Tax Assets, Goodwill and Intangible Assets as first filed |
|---|---|---|
| 2023-12-31 | $18.68M 10-K · filed 2024-03-29 | |
| 2022-12-31 | $13.21M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $10.43M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $7.87M 10-K · filed 2022-03-25 | |
| 2019-12-31 | $5.94M 10-K · filed 2021-03-31 | $5.94M 10-K · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |